These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3318839)

  • 1. T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action.
    Colombani PM; Hess AD
    Biochem Pharmacol; 1987 Nov; 36(22):3789-93. PubMed ID: 3318839
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
    Hess AD; Esa AH; Colombani PM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):29-40. PubMed ID: 2834840
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
    Colombani PM; Bright EC; Monastyrskyj O; Hess AD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1171-4. PubMed ID: 2950628
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes.
    Simons JW; Noga SJ; Colombani PM; Beschorner WE; Coffey DS; Hess AD
    J Cell Biol; 1986 Jan; 102(1):145-50. PubMed ID: 3484481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.
    Ryffel B
    Pharmacol Rev; 1990 Sep; 41(3):407-22. PubMed ID: 2185492
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cyclosporine A on early stages of T cell activation.
    Isakov N; Scholz W; Altman A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1186-8. PubMed ID: 3493569
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine sensitivity of human alloreactive T lymphocytes depends on the strength of the allogeneic stimulus.
    Kunkl A; Fenoglio D; Manca F; Caltabellotta M; Barocci S; Carozzi S; Valente U; Gessaga M; Celada F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):262. PubMed ID: 2978901
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of cyclosporin action: in vitro studies.
    Ryffel B
    Ann Inst Pasteur Immunol; 1987; 138(4):635-9. PubMed ID: 3499916
    [No Abstract]   [Full Text] [Related]  

  • 12. [T lymphocyte activation and its inhibition by cyclosporin A].
    Ryffel B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):615-6. PubMed ID: 3497420
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
    Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
    Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
    [No Abstract]   [Full Text] [Related]  

  • 14. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine A modulates the proliferation of T-lymphocyte colony forming cell subpopulations.
    Tice DG; Reinitz ER
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1191-2. PubMed ID: 3274305
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes.
    Buurman WA; Daemen AJ; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1193. PubMed ID: 3152624
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine action in blockade of cellular immune responses.
    Lorber MI
    Year Immunol; 1986; 2():279-88. PubMed ID: 3554824
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.